Multiparametric cardiac magnetic resonance in patients with thalassemia intermedia: new insights from the E-MIOT network

Weatherall DJ (1997) The thalassaemias. Bmj 314:1675–1678

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sturgeon P, Itano HA, Bergren WR (1955) Genetic and biochemical studies of intermediate types of Cooley’s anaemia. Br J Haematol 1:264–277

Article  CAS  PubMed  Google Scholar 

Taher AT, Musallam KM, El-Beshlawy A et al (2010) Age-related complications in treatment-naive patients with thalassaemia intermedia. Br J Haematol 150:486–489

Article  PubMed  Google Scholar 

Taher AT, Musallam KM, Karimi M et al (2010) Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the optimal care study. Blood 115:1886–1892

Article  CAS  PubMed  Google Scholar 

Haddad A, Tyan P, Radwan A, Mallat N, Taher A (2014) Beta-thalassemia intermedia: a bird’s-eye view. Turk J Haematol 31:5–16

Article  PubMed  PubMed Central  Google Scholar 

Ricchi P, Meloni A, Pistoia L et al (2020) Longitudinal follow-up of patients with thalassaemia intermedia who started transfusion therapy in adulthood: a cohort study. Br J Haematol 191:107–114

Article  CAS  PubMed  Google Scholar 

Ginzburg Y, Rivella S (2011) beta-thalassemia: a model for elucidating the dynamic regulation of ineffective erythropoiesis and iron metabolism. Blood 118:4321–4330

Article  CAS  PubMed  PubMed Central  Google Scholar 

Origa R, Galanello R, Ganz T et al (2007) Liver iron concentrations and urinary hepcidin in beta-thalassemia. Haematologica 92:583–588

Article  CAS  PubMed  Google Scholar 

Pennell DJ, Udelson JE, Arai AE et al (2013) Cardiovascular function and treatment in beta-thalassemia major: a consensus statement from the American Heart Association. Circulation 128:281–308

Article  CAS  PubMed  Google Scholar 

Origa R, Barella S, Argiolas GM, Bina P, Agus A, Galanello R (2008) No evidence of cardiac iron in 20 never- or minimally-transfused patients with thalassemia intermedia. Haematologica 93:1095–1096

Article  PubMed  Google Scholar 

Roghi A, Cappellini MD, Wood JC et al (2010) Absence of cardiac siderosis despite hepatic iron overload in Italian patients with thalassemia intermedia: an MRI T2* study. Ann Hematol 89:585–589

Article  CAS  PubMed  Google Scholar 

Liguori C, Pitocco F, Di Giampietro I et al (2015) Magnetic resonance comparison of left-right heart volumetric and functional parameters in thalassemia major and thalassemia intermedia patients. Biomed Res Int 2015:857642

Article  PubMed  PubMed Central  Google Scholar 

Taher AT, Musallam KM, Wood JC, Cappellini MD (2010) Magnetic resonance evaluation of hepatic and myocardial iron deposition in transfusion-independent thalassemia intermedia compared to regularly transfused thalassemia major patients. Am J Hematol 85:288–290

Article  CAS  PubMed  Google Scholar 

Meloni A, Pistoia L, Gamberini MR et al (2021) The link of pancreatic iron with glucose metabolism and cardiac iron in thalassemia intermedia: a large multicenter observational study. J Clin Med 10:5561

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ricchi P, Meloni A, Pistoia L et al (2018) The effect of desferrioxamine chelation versus no therapy in patients with non-transfusion-dependent thalassaemia: a multicenter prospective comparison from the MIOT network. Ann Hematol 97:1925–1932

Article  CAS  PubMed  Google Scholar 

Aessopos A, Berdoukas V (2009) Cardiac function and iron chelation in thalassemia major and intermedia: a review of the underlying pathophysiology and approach to chelation management. Mediterr J Hematol Infect Dis 1:e2009002

PubMed  PubMed Central  Google Scholar 

Marsella M, Borgna-Pignatti C, Meloni A et al (2011) Cardiac iron and cardiac disease in males and females with transfusion-dependent thalassemia major: a T2* magnetic resonance imaging study. Haematologica 96:515–520

Article  PubMed  PubMed Central  Google Scholar 

Aquaro GD, Camastra G, Monti L et al (2016) Reference values of cardiac volumes, dimensions, and new functional parameters by MR: a multicenter, multivendor study. J Magn Reson Imaging 45:1055–1067

Article  PubMed  Google Scholar 

Pepe A, Positano V, Capra M et al (2009) Myocardial scarring by delayed enhancement cardiovascular magnetic resonance in thalassaemia major. Heart 95:1688–1693

Article  CAS  PubMed  Google Scholar 

Assomull RG, Prasad SK, Lyne J et al (2006) Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 48:1977–1985

Article  PubMed  Google Scholar 

Bruder O, Wagner A, Jensen CJ et al (2010) Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 56:875–887

Article  PubMed  Google Scholar 

Pepe A, Meloni A, Rossi G et al (2018) Prediction of cardiac complications for thalassemia major in the widespread cardiac magnetic resonance era: a prospective multicentre study by a multi-parametric approach. Eur Heart J Cardiovasc Imaging 19:299–309

Article  PubMed  Google Scholar 

Kirk P, Roughton M, Porter JB et al (2009) Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major. Circulation 120:1961–1968

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pepe A, Pistoia L, Gamberini MR et al (2022) National networking in rare diseases and reduction of cardiac burden in thalassemia major. Eur Heart J 43:2482–2492

Article  PubMed  Google Scholar 

Ramazzotti A, Pepe A, Positano V et al (2009) Multicenter validation of the magnetic resonance t2* technique for segmental and global quantification of myocardial iron. J Magn Reson Imaging 30:62–68

Article  PubMed  Google Scholar 

Meloni A, Restaino G, Borsellino Z et al (2014) Different patterns of myocardial iron distribution by whole-heart T2* magnetic resonance as risk markers for heart complications in thalassemia major. Int J Cardiol 177:1012–1019

Article  PubMed  Google Scholar 

Meloni A, Luciani A, Positano V et al (2011) Single region of interest versus multislice T2* MRI approach for the quantification of hepatic iron overload. J Magn Reson Imaging 33:348–355

Article  PubMed  Google Scholar 

Cerqueira MD, Weissman NJ, Dilsizian V et al (2002) Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the cardiac imaging committee of the council on clinical cardiology of the American Heart association. Circulation 105:539–542

Article  PubMed  Google Scholar 

Wood JC, Enriquez C, Ghugre N et al (2005) MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. Blood 106:1460–1465

Article  CAS  PubMed  PubMed Central  Google Scholar 

Meloni A, Rienhoff HY Jr, Jones A, Pepe A, Lombardi M, Wood JC (2013) The use of appropriate calibration curves corrects for systematic differences in liver R2* values measured using different software packages. Br J Haematol 161:888–891

Article  PubMed  PubMed Central  Google Scholar 

Meloni A, Righi R, Missere M et al (2021) Biventricular reference values by body surface area, age, and gender in a large cohort of well-treated thalassemia major patients without heart damage using a multiparametric CMR approach. J Magn Reson Imaging 53:61–70

Article  PubMed  Google Scholar 

Anderson LJ, Holden S, Davis B et al (2001) Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 22:2171–2179

Article  CAS  PubMed  Google Scholar 

Positano V, Pepe A, Santarelli MF et al (2007) Standardized T2* map of normal human heart in vivo to correct T2* segmental artefacts. NMR Biomed 20:578–590

Article  PubMed  Google Scholar 

Carpenter JP, He T, Kirk P et al (2011) On T2* magnetic resonance and cardiac iron. Circulation 123:1519–1528

Article  PubMed  PubMed Central  Google Scholar 

Meloni A, Martini N, Positano V et al (2021) Myocardial iron overload by cardiovascular magnetic resonance native segmental T1 mapping: a sensitive approach that correlates with cardiac complications. J Cardiovasc Magn Reson 23:70

Article  PubMed  PubMed Central  Google Scholar 

Cogliandro T, Derchi G, Mancuso L et al (2008) Guideline recommendations for heart complications in thalassemia major. J Cardiovasc Med (Hagerstown) 9:515–525

Article  PubMed  Google Scholar 

Jessup M, Abraham WT, Casey DE et al (2009) 2009 focused update: ACCF/AHA guidelines for the diagnosis and management of heart failure in adults: a report of the American college of cardiology Foundation/American heart association task force on practice guidelines: developed in collaboration with the international society for heart and lung transplantation. Circulation 119:1977–2016

Article  PubMed 

留言 (0)

沒有登入
gif